Content area

|
|

Autoimmun pankreatitis

Forfatter(e)
Benjamin Petersen & Ove B. Schaffalitzky de Muckadell
Afdeling for Medicinske Mavetarmsygdomme, Odense Universitetshospital

Ugeskr Læger 2019;181:V07190398
Reference: 
Ugeskr Læger 2019;181:V07190398
Blad nummer: 

Benjamin Petersen & Ove B. Schaffalitzky de Muckadell:

Autoimmune pancreatitis

Ugeskr Læger 2019;181:V07190398

The aim of this review is to summarise the status of autoimmune pancreatitis (AIP), which is a rare disease, occasionally misdiagnosed as pancreatic cancer.
AIP consists of two distinct types, which differ in histopathology, association with other diseases and age of onset. Clinically, it is characterised by obstructive jaundice and abdominal pain. The disease shows rapid response to steroids. Rituximab can also be used as induction therapy. Often long-term treatment is necessary to maintain remission.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Knud Raben-Pedersen | 21/09
6 kommentarer
af Peter Matzen | 21/09
1 Kommentar
af Finn Vallø Hansen | 21/09
1 Kommentar
af Johan Ludvig Reventlow | 19/09
2 kommentarer
af Andreas Gothardt Lundh | 17/09
1 Kommentar
af Bjørn Søeberg | 17/09
33 kommentarer
af Lene Annette Norberg | 15/09
5 kommentarer
af Søren Holm | 14/09
1 Kommentar